Firebrick Pharma Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Peter Molloy

Chief executive officer

AU$351.3k

Total compensation

CEO salary percentage80.7%
CEO tenure12yrs
CEO ownership17.2%
Management average tenure3.3yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

Aug 14
Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

May 02
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Dec 14
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

Aug 30
Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Peter Molloy's remuneration changed compared to Firebrick Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$5m

Sep 30 2023n/an/a

-AU$6m

Jun 30 2023AU$351kAU$284k

-AU$7m

Mar 31 2023n/an/a

-AU$6m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$5m

Jun 30 2022AU$324kAU$252k

-AU$4m

Mar 31 2022n/an/a

-AU$3m

Dec 31 2021n/an/a

-AU$3m

Sep 30 2021n/an/a

-AU$3m

Jun 30 2021AU$140kAU$140k

-AU$2m

Compensation vs Market: Peter's total compensation ($USD228.31K) is about average for companies of similar size in the Australian market ($USD290.69K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.


CEO

Peter Molloy (69 yo)

12yrs

Tenure

AU$351,298

Compensation

Dr. Peter Laurence Molloy, BSc, MBA, FAICD is the Founder, Executive Chairman and Chief Executive Officer of Firebrick Pharma Limited since April 12, 2012. He served as Managing Director and Chief Executiv...


Leadership Team

NamePositionTenureCompensationOwnership
Peter Molloy
Founder12yrsAU$351.30k17.24%
A$ 2.0m
Stephen Goodall
Founder12yrsAU$290.56k17.24%
A$ 2.0m
Kavi Bekarma
Chief Financial Officer1.3yrsno datano data
Simon Tucker
Chief Scientific Officerno datano data0.56%
A$ 65.0k
Peter Friedland
Chief Medical Officerno datano datano data
Monique Baldwin
Head of Regulatory Affairs2.3yrsno datano data
Stephen Buckley
Company Secretary3.3yrsno datano data

3.3yrs

Average Tenure

Experienced Management: FRE's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Molloy
Founder12yrsAU$351.30k17.24%
A$ 2.0m
Stephen Goodall
Founder12yrsAU$290.56k17.24%
A$ 2.0m
Phyllis Gardner
Independent Non-Executive Director3.4yrsAU$75.00k0.34%
A$ 39.0k
Richard Treagus
Non-Executive Director1.8yrsAU$50.00kno data

7.7yrs

Average Tenure

Experienced Board: FRE's board of directors are considered experienced (7.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.